Picture of Moberg Pharma AB (publ) logo

MOB Moberg Pharma AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Moberg Pharma Q4 EBITDA Loss At SEK 5.7 Million

Aug 11 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * JUNE 2020
    * Q4 NET REVENUE SEK 0.0 MILLION (0.0)
    * Q4 EBITDA SEK -5.7 MILLION (-8.5)

Source text for Eikon:  ID:nWkr7ZQJfh 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Moberg Pharma AB (publ)

See all news